- Market Realist•2 days ago
Novartis (NVS) is set to release its 4Q16 earnings on January 25, 2017. Analysts estimate its 4Q16 earnings per share to be $1.12.
- Bloomberg•3 days ago
Joe Jimenez, Novartis chief executive officer, discusses the outlook for the pharmaceutical industry under President Donald Trump. He speaks with Bloomberg's Erik Schatzker at the World Economic Forum ...
- Market Realist•5 days ago
The overall contribution of the innovative medicines segment was ~67% at $8,173 million for 3Q16.
NVS.BA : Summary for NOVARTIS AG CEDEAR EACH REP 0.5 - Yahoo Finance
NOVARTIS AG CEDEAR EACH REP 0.5 (NVS.BA)
Buenos Aires - Buenos Aires Delayed Price. Currency in ARS
Add to watchlist
|Day's Range||566.85 - 566.85|
|52 Week Range||566.85 - 585.00|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|